What has AlphaFold3 learned about antibody and nanobody docking, and what remains unsolved?
Fatima N. Hitawala, Jeffrey J. Gray
This study evaluates AlphaFold3's ability to predict antibody and nanobody structures and their docking with antigens, finding high accuracy but significant room for improvement.